A Placebo-Controlled, Parallel-Group, Randomized Clinical Trial of AC-1204 in Mild-to-Moderate Alzheimer’s Disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Placebo-Controlled, Parallel-Group, Randomized Clinical Trial of AC-1204 in Mild-to-Moderate Alzheimer’s Disease
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 75, Issue 2, Pages 547-557
Publisher
IOS Press
Online
2020-04-15
DOI
10.3233/jad-191302
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- APOE alters glucose flux through central carbon pathways in astrocytes
- (2020) Holden C. Williams et al. NEUROBIOLOGY OF DISEASE
- Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function
- (2019) Adam L. Orr et al. JOURNAL OF ALZHEIMERS DISEASE
- Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study
- (2018) Nare Torosyan et al. EXPERIMENTAL GERONTOLOGY
- Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer’s Disease
- (2018) Etienne Croteau et al. JOURNAL OF ALZHEIMERS DISEASE
- Sporadic Alzheimer's Disease: The Starving Brain
- (2018) Mortimer Mamelak JOURNAL OF ALZHEIMERS DISEASE
- Lower Brain 18F-Fluorodeoxyglucose Uptake But Normal 11C-Acetoacetate Metabolism in Mild Alzheimer's Disease Dementia
- (2018) Christian-Alexandre Castellano et al. JOURNAL OF ALZHEIMERS DISEASE
- Glucose deficit triggers tau pathology and synaptic dysfunction in a tauopathy mouse model
- (2017) E Lauretti et al. Translational Psychiatry
- Suspected non-Alzheimer disease pathophysiology — concept and controversy
- (2016) Clifford R. Jack et al. Nature Reviews Neurology
- Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer’s Disease
- (2016) Stephen C. Cunnane et al. Frontiers in Molecular Neuroscience
- Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer’s disease?
- (2016) Maowen Ba et al. Translational Neurodegeneration
- Alzheimer's Disease
- (2013) Carly Oboudiyat et al. SEMINARS IN NEUROLOGY
- Cerebral blood flow and metabolic rate of oxygen, glucose, lactate, pyruvate, ketone bodies and amino acids
- (2010) Ulla Lying-Tunell et al. ACTA NEUROLOGICA SCANDINAVICA
- Dietary ketosis enhances memory in mild cognitive impairment
- (2010) Robert Krikorian et al. NEUROBIOLOGY OF AGING
- Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial
- (2009) Samuel T Henderson et al. Nutrition & Metabolism
- Phosphorylation of the Translation Initiation Factor eIF2α Increases BACE1 Levels and Promotes Amyloidogenesis
- (2008) Tracy O'Connor et al. NEURON
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started